Canadian generics group hits out at trade deal

09-10-2018

Canadian generics group hits out at trade deal

-oxford- / iStockphoto.com

The IP concessions in the United States-Mexico-Canada Agreement (USMCA) are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association (CGPA).


NAFTA, CGPA, USMCA, trade agreement, generics, biologic drugs, market exclusivity, affordable healthcare, CETA, healthcare

LSIPR